Skip to content
  • Essence GU
  • Beautycon
  • NaturallyCurly
  • Afropunk
  • Essence Studios
  • Soko Mrkt
  • Ese Funds
  • Refinery29
  • WeLoveUs.shop
  • 2026 ESSENCE Festival Of Culture
  • Celebrity
  • Fashion
  • Beauty
  • Lifestyle
  • Entrepreneurship
  • News
  • Shopping
  • Video
  • Events
  • Subscribe
Home • Health & Wellness
Presented By
Merck

Let's Talk Trials: Making Clinical Trials More Inclusive

Sponsored by Merck
Let's Talk Trials: Making Clinical Trials More Inclusive
By Essence · Updated February 4, 2026
Getting your Trinity Audio player ready…

Progress in medicine is made possible through the contributions of many people, including patients, families, caregivers, and health care professionals who support and participate in clinical research. Clinical trials, a type of clinical research, help researchers understand how our bodies respond to investigational medicines or other treatments. They explore new ways to prevent, find, diagnose or treat diseases. They also help determine whether investigational treatments or new uses for existing treatments are safe and work well. It’s only through clinical trials that investigational medicines, treatments and devices can be approved for public use.  

Diseases can impact people differently based on their age, gender, weight, race, ethnicity and other factors, so it’s important for clinical trials to include people from a wide variety of backgrounds. Historically, communities of color have had limited access to clinical trials despite facing higher burdens of many diseases. It’s important that clinical trial participants represent the population of people most impacted by the disease, so the data from the research appropriately reflects who the medicines and vaccines are designed to help. There are many barriers that keep people of all backgrounds from participating in clinical trials, including lack of awareness, mistrust, location and transportation challenges.

That’s why Merck, a global biopharmaceutical company, launched the Let’s Talk Trials campaign and educational website. This initiative is designed to spark meaningful conversations, provide resources and advance inclusive research to help build a future of health care that’s representative of all communities. People like Danielle Mitchell — a clinical research professional, leader and advocate — share this mission.

Danielle’s Mission: Creating Opportunities
Danielle Mitchell, CEO and founder of Black Women in Clinical Research (BWICR), embodies the spirit of Let’s Talk Trials. Her story is one of resilience and self-advocacy, breaking down barriers and creating opportunities not only for herself, but for thousands of Black women across the country.

Danielle has spent more than eight years creating a space dedicated to education, empowerment and support for other Black women pursuing careers in clinical research. BWICR began as a small online community and has grown into a supportive network that opens doors, provides mentorship and expands opportunities across the field. Through mentorship and shared knowledge, BWICR empowers more women to enter the field and strengthens representation across the industry.

“Research shows that Black patients are more likely to participate in clinical trials when their providers reflect their background,” Danielle says. “That’s why BWICR is so important. By creating pathways for more Black professionals to enter and lead in this space, we’re also helping to create the trust needed to make clinical trials more inclusive.”

Article continues after video.

A Shared Future: Why Representation Matters
Danielle’s story reflects the larger mission of Let’s Talk Trials: reshaping clinical research so it reflects all communities. Representation in clinical trials remains a challenge, and addressing these gaps requires continued trust-building, awareness and community engagement.

“Real change happens when people feel seen, informed and included,” says Adrelia Allen, Executive Director of Clinical Trial Patient Diversity at Merck. “Every person who takes part in a clinical trial has the power to contribute to data that may help future generations. Through Let’s Talk Trials, we’re encouraging people to learn more about the importance of representation in clinical trials and join the conversation.”

Let’s Talk Trials focuses on building trust, expanding access through education and amplifying authentic voices to create meaningful dialogue. Encouraging open and honest conversations, addressing common myths and increasing awareness are all critical to help advance inclusive clinical research.

Join the Conversation
Danielle’s journey is a reminder that progress happens when voices from the community are heard and represented. By using her voice to uplift others and advocate for greater inclusion in clinical research, she’s showing what real change looks like.  Together, we can help create a future of health care that’s inclusive and representative of all communities.

Join us in conversation at LetsTalkClinicalTrials.com.